School of Pharmacy to collaborate with AstraZeneca in type 2-diabetes research_澳门皇冠体育,皇冠足球比分

Bjarne R?sj?
2016-11-06T23:00:00.000Z
type:structured-article
www.uio.no

The University of Oslo has entered a five-year research agreement with AstraZeneca in the area of type 2 diabetes. As part of the agreement, four researchers from the University will work at AstraZeneca’s laboratories in Sweden.